Aardvark Therapeutics, Inc. Common Stock (AARD) vs Cibus, Inc. (CBUS)

A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and Cibus, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AARD

Aardvark Therapeutics, Inc. Common Stock

$108M

$4.95HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

CBUS

Cibus, Inc.

$121M

$1.58HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — AARD vs CBUS

growth of $100 · dividends reinvested · last 2y

AARD -63.5% (-39.6%/yr)CBUS -33.6% (-18.5%/yr)CBUS compounded faster over this window

AARD CBUS

AARD vs CBUS: by the numbers

•CBUS is the larger company ($121M vs $108M market cap).
•Both run net losses; AARD's is the smaller (0.00% vs -2258.89% net margin).

Metrics side by side

Valuation

Metric	AARD	CBUS
P/S ratio	N/A	27.74
P/B ratio	1.45	8.15

Profitability

Metric	AARD	CBUS
Gross margin	0.00%	-62.76%
Operating margin	0.00%	-1853.92%
Net margin	0.00%	-2258.89%
ROE	-93.44%	-663.38%
ROIC	-97.99%	-17.99%

Growth (annualized)

Metric	AARD	CBUS
Revenue CAGR (5Y)	N/A	-34.28%
Total return CAGR (5Y)	N/A	-59.70%

Go deeper

Full AARD analysis Full CBUS analysis Interactive comparison tool

Dig into the metrics

Aardvark Therapeutics, Inc. Common Stock ROE Cibus ROE Aardvark Therapeutics, Inc. Common Stock operating margin Cibus operating margin Aardvark Therapeutics, Inc. Common Stock revenue growth Cibus revenue growth Aardvark Therapeutics, Inc. Common Stock free cash flow Cibus free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.